Ilevro

Chronic Pain, Inflammation, Cataract Surgery

Treatment

5 FDA approvals

20 Active Studies for Ilevro

What is Ilevro

Nepafenac

The Generic name of this drug

Treatment Summary

Nepafenac is a medication used to treat pain and inflammation after cataract surgery. It is an NSAID (non-steroidal anti-inflammatory drug) that comes in the form of a prescription eye drop.

Nevanac

is the brand name

image of different drug pills on a surface

Ilevro Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Nevanac

Nepafenac

2005

5

Approved as Treatment by the FDA

Nepafenac, also known as Nevanac, is approved by the FDA for 5 uses like Pain and Inflammation .

Pain

Helps manage Pain

Inflammation

Helps manage Inflammation

Chronic Pain

Helps manage Pain

Cataract Surgery

Helps manage Cataract Surgery

Inflammation

Helps manage Inflammation

Effectiveness

How Ilevro Affects Patients

When Nepafenac ophthalmic suspension is taken three times a day, measurable amounts of Nepafenac and Amfenac are present in the blood after two and three hours respectively. On average, the maximum amount of Nepafenac and Amfenac in the blood was 0.310 and 0.422 nanograms per milliliter, respectively.

How Ilevro works in the body

Nepafenac is a drug that is changed in the body to amfenac, a type of pain reliever. Amfenac works by blocking the activity of two enzymes, COX1 and COX2. This helps reduce inflammation and pain.

When to interrupt dosage

The recommended measure of Ilevro is contingent upon the diagnosed condition, for example Inflammation, Cataract Surgery and Chronic Pain. The quantity of dosage fluctuates, according to the administration mode (e.g. Suspension / drops or Ophthalmic) featured in the table beneath.

Condition

Dosage

Administration

Chronic Pain

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Cataract Surgery

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Inflammation

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Warnings

Ilevro Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Ilevro.

Common Ilevro Drug Interactions

Drug Name

Risk Level

Description

Valproic acid

Minor

The protein binding of Valproic acid can be decreased when combined with Nepafenac.

Acemetacin

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Acemetacin.

Acetylsalicylic acid

Moderate

The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Nepafenac.

Alclofenac

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Alclofenac.

Alminoprofen

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Alminoprofen.

Ilevro Toxicity & Overdose Risk

Applying non-steroidal anti-inflammatory drugs to the eyes can lead to increased bleeding in the eye area during eye surgery.

image of a doctor in a lab doing drug, clinical research

Ilevro Novel Uses: Which Conditions Have a Clinical Trial Featuring Ilevro?

357 active studies are currently being undertaken to assess the potential of Ilevro in alleviating Inflammation, Chronic Pain and assisting with Cataract Surgery.

Condition

Clinical Trials

Trial Phases

Inflammation

58 Actively Recruiting

Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4

Chronic Pain

130 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1

Cataract Surgery

3 Actively Recruiting

Not Applicable, Phase 4

Ilevro Reviews: What are patients saying about Ilevro?

5

Patient Review

8/28/2016

Ilevro for Inflammation of the Eye Following Surgery

I took this treatment once a day for 7 days, and then due to irritation from the antibiotic, I dropped down to 2 drops a day for 7 days. I had a sample bottle which only lasted me until day 11. From my experience, I think that one bottle would last if you're only taking 1 drop a day for two weeks. However, since I ran out before finishing the full 14 days, I had to get a prescription for the other eye. This medication is pricey, but my insurance did give me a special authorization and covered it.

5

Patient Review

6/17/2017

Ilevro for Inflammation of the Eye Following Surgery

Helped to relieve pain after a failed glaucoma surgery. Not as easy to apply as OTC eyedrops, but this was much more effective and long-lasting.

4

Patient Review

10/29/2013

Ilevro for Inflammation of the Eye Following Surgery

3.3

Patient Review

1/1/2014

Ilevro for Inflammation of the Eye Following Surgery

The bottle was very small and expensive. The design of the bottle tip was such that the medication would drip down the side of the bottle after application, wasting a small amount each time. Other eye drops I used had better tip design.

3

Patient Review

3/22/2019

Ilevro for Inflammation of the Eye Following Surgery

I used this once in the morning and evening for cataracts/LASIK and it did the job well. The only side effect was temporary blurring, but that was manageable. The bottle is really difficult to use though.

2

Patient Review

3/26/2016

Ilevro for Postoperative Pain in Eye

The bottle is rigid, and the fluid inside is very viscous. It barely lasted me three weeks. Since it's not a covered medication, unless you're careful with your usage, you'll end up having to pay for another bottle before you're supposed to.

1.7

Patient Review

8/8/2014

Ilevro for Postoperative Pain in Eye

The design of this dropper is very poor. There is only enough medicine for 25 days, so you have to be careful when using it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ilevro

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug Ilevro used for?

"This medication is used to relieve eye pain, irritation, and redness following cataract eye surgery. Nepafenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs work by reducing swelling and inflammation."

Answered by AI

What are the side effects of Ilevro eye drops?

"The sensation of a foreign body in the eye, increased intraocular pressure, a sticky sensation in the eye, eye or eyelid swelling, dry eye, crusting of the eyelids, eye discomfort or pain, and itchy eyes are all symptoms of conjunctivitis."

Answered by AI

What kind of drug is Ilevro?

"Ilevro is a non-steroidal anti-inflammatory drug (NSAID) that lessens pain and swelling in the eye due to surgery by stopping your body from making chemicals that cause inflammation."

Answered by AI

Is Ilevro a generic drug?

"At the moment, there is no cheaper alternative to Ilevro that has the same therapeutic effect in the United States. Be aware that there are many illegal online pharmacies that might try to sell you a generic version of Ilevro. These medicines could be fake and potentially dangerous."

Answered by AI

Clinical Trials for Ilevro

Image of Exercise and Performance Nutrition Laboratory in Saint Charles, United States.

Multi-Strain Postbiotic for Inflammation and Gastrointestinal Symptoms

18 - 55
All Sexes
Saint Charles, MO

This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplementation alters physiological and perceptual responses to a standardized bout of moderate-to-high intensity exercise compared with placebo. Approximately 50 healthy men and women aged 18 to 55 years will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Participants will be randomly assigned to receive either a multi-strain postbiotic supplement or a matched placebo for 28 days. At the end of the supplementation period, participants will complete a 45-minute treadmill exercise bout at 75% of their individually determined maximum heart rate. Blood samples will be collected to assess biomarkers of inflammation, immune activity, and recovery. Gastrointestinal symptoms, intestinal permeability, anxiety, and perceived recovery will be evaluated using validated questionnaires. This study is designed to determine whether postbiotic supplementation modulates physiological stress responses and subjective well-being following prolonged exercise in healthy adults.

Waitlist Available
Paid Trial

Exercise and Performance Nutrition Laboratory

Chad M Kerksick, PhD

Image of Cincinnati Urogynecology Associates in Cincinnati, United States.

Nitrous Oxide for Pain During Bladder Botox Injections

18+
Female
Cincinnati, OH

The goal of this clinical trial is to assess if a mix of nitrous oxide and oxygen can improve pain control during bladder Botox injections. The primary question it aims to answer is: Does using nitrous oxide lower the overall level of pain during the procedure? Researchers will compare a 50:50 nitrous oxide/oxygen mixture (administered with the Pro-Nox system) plus standard care (with lidocaine in the bladder) to sham mask plus standard care to see if nitrous oxide works better for lowering pain. Participants will: * Receive their bladder Botox injection in the office setting * Either use nitrous oxide/oxygen plus standard care during the procedure, or sham mask plus standard care * Answer brief questions about pain, anxiety, satisfaction, and willingness to repeat the procedure

Phase 4
Waitlist Available

Cincinnati Urogynecology Associates (+1 Sites)

Image of ATX Hyperbarics in Austin, United States.

Hyperbaric Oxygen Therapy for Cardiovascular Fitness

30 - 60
All Sexes
Austin, TX

The purpose of this study is to determine whether hyperbaric oxygen therapy (HBOT) at 1.75 atmospheres of pressure (ATA) improves cardiovascular fitness (VO₂ max) and reduces inflammation in healthy adults. HBOT involves breathing pure oxygen in a pressurized chamber and is considered investigational for this use. Recent research has shown that different HBOT pressures can have different effects on inflammation. Specifically, some inflammatory cytokines (measurable markers of inflammation in the body) appear to decrease at low pressures like 1.3 ATA, while a different set of cytokines responds better at higher pressures, such as 2.0 ATA. Cytokines are small proteins that play a crucial role in cell signaling, particularly within the immune system. They help regulate inflammation, infection response, and overall immune function. While some cytokines promote inflammation to fight off threats, others help reduce inflammation when it's no longer needed. An imbalance in cytokines - especially excessive inflammatory cytokines - can contribute to chronic inflammation, cardiovascular disease, and other health issues. In this study, we are testing an intermediate pressure - 1.75 ATA - to see if we can target both sets of cytokines at once. If successful, this approach could offer broader anti-inflammatory benefits. We are also interested in how this intermediate pressure may improve VO₂ max, a key indicator of cardiovascular fitness. Since VO₂ max is strongly linked to heart health and overall longevity, finding a safe and effective way to improve it has meaningful implications not just for athletes, but for anyone looking to enhance their fitness and well-being.

Recruiting
Has No Placebo

ATX Hyperbarics (+1 Sites)

Image of Montana State University in Bozeman, United States.

Haskap Berries for Exercise Performance Recovery

18 - 35
All Sexes
Bozeman, MT

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Recruiting
Paid Trial

Montana State University

Mary P Miles

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials
Image of Byers Eye Institute in Palo Alto, United States.

LLM-Based Education for Cataract Surgery

18+
All Sexes
Palo Alto, CA

Patients with cataracts disease need to choose what type of artificial lens will go into their eye prior to surgery date. Some lenses are standard and are usually covered by insurance. Other "premium" lenses have various benefits such as reducing the need for glasses but usually require out-of-pocket costs. The combined busy outpatient clinic and complexity of artificial lens choices in the ever-changing world of cataract surgery tends to lead patients confused about their available lens options. There is an abundance of educational material present in premium lenses, however these are limited by accessibility and are standardized at single educational levels. Therefore in the present study, we want to test whether giving patients a short LLM powered AI-guided explanation from Custom GPT from OpenAI of lens options prior to their consultation with their doctor can improve visit efficiency, physician explanation and patient understanding of lens options. We will compare two groups: standard of care versus standard of care plus AI education. The LLM in this study is intended to provide supplemental information about premium intraocular lens(IOLs) options to study participants, and is no means supposed to replace a health care professional in the diagnosis, cure, treatment, and/or mitigation of disease. Study is analogous to giving a verified health pamphlet to a patient for them to view and learn different IOL options, in other words, facilitating patient understanding of their options. The LLM will be trained by several health care professionals and MD specialists to provide sufficient instructions. Sources will include verified online resources and MD information. The investigators hope to learn if a large language model-based educational tool can improve visit efficiency, physician explanation and patient understanding of intraocular lens options. New knowledge of this study could guide how cataract counseling is delivered in the future and may help clinics spend more time on individualized questions instead of repeating generic information.

Waitlist Available
Has No Placebo

Byers Eye Institute

Robert T Chang, MD

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials